First Time Loading...

ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 6.72 USD -4.95% Market Closed
Updated: Apr 19, 2024

ESSA Pharma Inc
Net Income (Common)

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

ESSA Pharma Inc
Net Income (Common) Peer Comparison

Comparables:
ZYME
FUSN
AUPH
SBFM

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
ESSA Pharma Inc
NASDAQ:EPIX
Net Income (Common)
$-25.8m
CAGR 3-Years
-1%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Net Income (Common)
$-118.7m
CAGR 3-Years
13%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Net Income (Common)
$-94.9m
CAGR 3-Years
-6%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Net Income (Common)
$-78m
CAGR 3-Years
9%
CAGR 5-Years
-4%
CAGR 10-Years
-40%
Sunshine Biopharma Inc
OTC:SBFM
Net Income (Common)
$-4.5m
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-6%

See Also

What is ESSA Pharma Inc's Net Income (Common)?
Net Income (Common)
-25.8m USD

Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Net Income (Common) amounts to -25.8m USD.

What is ESSA Pharma Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-16%

Over the last year, the Net Income (Common) growth was 21%. The average annual Net Income (Common) growth rates for ESSA Pharma Inc have been -1% over the past three years , -16% over the past five years .